Shares of bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $106.00 and traded as low as $103.50. bioMérieux shares last traded at $103.50, with a volume of 10 shares trading hands.
bioMérieux Stock Down 2.5 %
The business’s 50 day moving average is $106.00 and its 200 day moving average is $108.07.
bioMérieux Company Profile
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Featured Articles
- Five stocks we like better than bioMérieux
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- How to Invest in the FAANG Stocks
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- How to Calculate Stock Profit
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
